methylprednisolone has been researched along with Malignant Melanoma in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 17 (60.71) | 24.3611 |
| 2020's | 5 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bruni, M; Girolomoni, G; Moar, A; Schena, D | 1 |
| Cooksley, T; Gupta, A; Marshall, W | 1 |
| Adam, JP; Bélanger, K; Chen, M; Florescu, M; Larochelle, C; Pigeon, M; Taillefer, VT | 1 |
| Arance, A; Ordás, I; Pesántez, D; Seguí, E; Viladot, M | 1 |
| Buzaid, AC; Fernandes, Í; Schvartsman, G; Souza, IL; Taranto, P | 1 |
| Cusnir, I; Habib, S; Hung, W; Smylie, M; Solez, K; Yacyshyn, E | 1 |
| Hendrickson, S; Shepard, B; Trower, C | 1 |
| Fusumae, T; Inoda, S; Kamiya, K; Kawashima, H; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Takahashi, R | 1 |
| Amini-Adle, M; Dalle, S; Dubois, V; Marabelle, A; Piperno, M; Thomas, L; Tordo, J | 1 |
| Hyams, C; Low, AT; Rickard, F | 1 |
| Aubin, F; Beaudoin, MA; Borg, C; Borot, S; Cattin, F; Gauthier, AS; Nardin, C; Puzenat, E; Schillo, F | 1 |
| Fukushima, S; Ihn, H; Itai, H; Kimura, T; Kubo, Y; Kuriyama, H; Miyamoto, H; Miyashita, A; Nakahara, S; Tsukamoto, H | 1 |
| Ludlow, SP; Pasikhova, Y | 1 |
| Burnette, WB; Clark, SW; Dickson, MA; Johnson, DB; Kudchadkar, RR; Lavin, PJ; Saranga-Perry, V; Sosman, JA; Uskavitch, DR; Wallace, DE | 1 |
| Fulcher, T; Kelly, R; McElnea, E; Moran, S; Ní Mhéalóid, A | 1 |
| Camacho-Martínez, FM; Cantalejo-Rodríguez, C; Fernández-Crehuet, P; Herrera-Saval, A; Pérez-Gil, A; Ríos-Martín, JJ | 1 |
| Bye, W; Cheng, R; Cooper, A; Kench, J; McNeil, C; Shackel, N; Watson, G | 1 |
| Ahmed, T; Black, J; Pandey, R; Shah, B | 1 |
| Hamaguchi, Y; Ikeda, T; Maeda, S; Matsushita, T; Nakao, M; Oishi, K; Takehara, K; Yamada, T | 1 |
| Helbig, D; Simon, JC; Treudler, R | 1 |
| Binder, M; Erasim, C; Harmankaya, K; Hoos, A; Ibrahim, R; Koelblinger, C; Pehamberger, H | 1 |
| Forde, PM; O'Byrne, KJ; Rock, K; Wilson, G | 1 |
| Garrott, H; O'Day, J | 1 |
| Kim, R; Shukla, D | 1 |
| Kramer, KK; Light, JA; Oakes, DD; Spees, EK; Zimmerman, LE | 1 |
| Tabassian, A; Zuravleff, JJ | 1 |
| Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M | 1 |
| Cowled, PA; Forbes, IJ; Mackenzie, L | 1 |
1 review(s) available for methylprednisolone and Malignant Melanoma
| Article | Year |
|---|---|
Ipilimumab-induced toxicities and the gastroenterologist.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Chemical and Drug Induced Liver Injury; Colitis; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Melanoma; Methylprednisolone; Mycophenolic Acid; Patient Care Team; Prednisolone; Pulse Therapy, Drug | 2015 |
1 trial(s) available for methylprednisolone and Malignant Melanoma
| Article | Year |
|---|---|
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Melanoma; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Sarcoma; Vomiting | 1992 |
26 other study(ies) available for methylprednisolone and Malignant Melanoma
| Article | Year |
|---|---|
A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Blister; Humans; Male; Melanoma; Methylprednisolone; Nivolumab; Pemphigoid, Bullous | 2022 |
Early infliximab in life-threatening immune-mediated pneumonitis.
Topics: Humans; Infliximab; Male; Melanoma; Methylprednisolone; Middle Aged; Pneumonia; Radiography, Thoracic; Tomography, X-Ray Computed; Tumor Necrosis Factor Inhibitors | 2019 |
Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.
Topics: Aged; Autoimmune Diseases; Humans; Limbic Encephalitis; Male; Melanoma; Methylprednisolone; Nivolumab; Prednisone | 2020 |
Successful management of refractory immune-mediated enterocolitis with cyclosporine.
Topics: Adult; Antineoplastic Agents, Immunological; Biopsy; Colon; Colonoscopy; Cyclosporine; Drug Resistance; Enterocolitis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Melanoma; Methylprednisolone; Programmed Cell Death 1 Receptor; Skin Neoplasms; Treatment Outcome | 2020 |
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Delayed Diagnosis; Diagnosis, Differential; Female; Glucocorticoids; Humans; Ipilimumab; Length of Stay; Liver Neoplasms; Lung; Male; Melanoma; Methylprednisolone; Nasopharynx; Neoplasms, Unknown Primary; Nivolumab; Pandemics; Pneumonia; Pneumonia, Viral; SARS-CoV-2; Time Factors; Time-to-Treatment; Tomography, X-Ray Computed; Uveal Neoplasms | 2020 |
Immune checkpoint inhibitor-induced granulomatosis with polyangiitis.
Topics: Aged; Diabetes Mellitus; Female; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Melanoma; Methylprednisolone; Neoplasm Recurrence, Local; Nivolumab; Renal Insufficiency, Chronic; Rituximab; Skin Neoplasms | 2021 |
Toxic Injury to the Gastrointestinal Tract After Ipilimumab Therapy for Advanced Melanoma.
Topics: Abdominal Pain; Biopsy, Needle; Colitis; Diarrhea; Emergency Service, Hospital; Endoscopy, Digestive System; Female; Gastrointestinal Tract; Humans; Immunohistochemistry; Infusions, Intravenous; Ipilimumab; Melanoma; Methylprednisolone; Neoplasm Invasiveness; Neoplasm Staging; Pain Measurement; Prognosis; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Young Adult | 2018 |
Vogt-Koyanagi-Harada disease-like uveitis induced by vemurafenib for metastatic cutaneous malignant melanoma.
Topics: Angiography; Antineoplastic Agents; Female; Humans; Melanoma; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Retina; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome; Vemurafenib | 2018 |
Remitting Seronegative Symmetric Synovitis With Pitting Edema Associated With Partial Melanoma Response Under Anti-CTLA-4 and Anti-Programmed Death 1 Combination Treatment.
Topics: Aged; Antineoplastic Agents, Immunological; CTLA-4 Antigen; Edema; Glucocorticoids; Humans; Ipilimumab; Male; Melanoma; Methylprednisolone; Nivolumab; Prednisone; Programmed Cell Death 1 Receptor; Synovitis | 2018 |
Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Computed Tomography Angiography; Continuous Positive Airway Pressure; Cough; Diagnosis, Differential; Dyspnea; Fatal Outcome; Glucocorticoids; Humans; Hypoxia; Intensive Care Units; Male; Melanoma; Methylprednisolone; Pneumonia; Programmed Cell Death 1 Receptor; Pulmonary Embolism | 2018 |
Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Humans; Inflammation; Lung Neoplasms; Male; Melanoma; Methylprednisolone; Orbital Diseases; Prognosis; Skin Neoplasms | 2019 |
Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.
Topics: Antineoplastic Agents, Immunological; Biopsy; Colitis; Colon; Colonoscopy; Dose-Response Relationship, Drug; Female; Humans; Intestinal Mucosa; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Methylprednisolone; Middle Aged; Nivolumab; Tomography, X-Ray Computed; Vaginal Neoplasms | 2019 |
Cumulative dermatologic toxicity with ipilimumab and vemurafenib responsive to corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Exanthema; Female; Humans; Indoles; Ipilimumab; Melanoma; Methylprednisolone; Mutation; Neoplasm Metastasis; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Time Factors; Treatment Outcome; Vemurafenib | 2013 |
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma.
Topics: Aged; Antibodies, Monoclonal; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Ipilimumab; Melanoma; Methylprednisolone; Myasthenia Gravis; Plasmapheresis; Risk Assessment; Sampling Studies; Severity of Illness Index; Skin Neoplasms; Survival Rate; Treatment Outcome | 2015 |
Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab.
Topics: Aged; Antibodies, Monoclonal; Euthyroid Sick Syndromes; Exophthalmos; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Ipilimumab; Melanoma; Methylprednisolone; Ophthalmoplegia; Thyroid Function Tests; Thyrotropin; Thyroxine | 2014 |
Dermatomyositis and malignant melanoma: a rare association that worsens prognosis?
Topics: Bone Neoplasms; Dermatomyositis; Female; Glucocorticoids; Humans; Interferon alpha-2; Interferon-alpha; Melanoma; Methylprednisolone; Middle Aged; Prognosis; Recombinant Proteins; Skin Neoplasms; Treatment Outcome | 2014 |
Resolution of ipilimumab induced severe hepatotoxicity with triple immunosuppressants therapy.
Topics: Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Australia; Chemical and Drug Induced Liver Injury; Female; Hepatitis; Horses; Humans; Immunosuppressive Agents; Ipilimumab; Melanoma; Methylprednisolone; Middle Aged; Mycophenolic Acid | 2015 |
A case of aseptic meningitis without neck rigidity occurring in a metastatic melanoma patient treated with ipilimumab.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Head and Neck Neoplasms; Humans; Ipilimumab; Male; Melanoma; Meningitis, Aseptic; Methylprednisolone; Middle Aged; Neuroprotective Agents; Skin Neoplasms | 2017 |
Urticaria, angioedema and dyspnoea in adjuvant therapy of melanoma with interferon alpha-2b.
Topics: Angioedema; Antineoplastic Agents; Chemotherapy, Adjuvant; Dimethindene; Drug Hypersensitivity; Dyspnea; Glucocorticoids; Histamine H1 Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Methylprednisolone; Middle Aged; Recombinant Proteins; Skin Neoplasms; Treatment Outcome; Urticaria | 2010 |
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Diarrhea; Fatigue; Female; Humans; Ipilimumab; Melanoma; Methylprednisolone; Middle Aged; Nausea; Skin Neoplasms; Vomiting | 2011 |
Ipilimumab-induced immune-related renal failure--a case report.
Topics: Acute Kidney Injury; Antibodies, Monoclonal; Creatinine; Glucocorticoids; Humans; Ipilimumab; Lymphatic Metastasis; Male; Melanoma; Methylprednisolone; Middle Aged; Radiography; Skin Neoplasms; Treatment Outcome | 2012 |
Optic neuropathy secondary to radiotherapy for nasal melanoma.
Topics: Aged; Anticoagulants; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Melanoma; Methylprednisolone; Optic Nerve; Optic Nerve Diseases; Paranasal Sinus Neoplasms; Radiation Injuries; Radiotherapy; Visual Fields; Warfarin | 2004 |
Giant nodular posterior scleritis simulating choroidal melanoma.
Topics: Choroid Neoplasms; Diagnosis, Differential; Female; Follow-Up Studies; Glucocorticoids; Humans; Melanoma; Methylprednisolone; Middle Aged; Scleritis; Ultrasonography | 2006 |
Reactivation of ocular malignant melanoma after renal transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Eye Neoplasms; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Melanoma; Methylprednisolone; Pyelonephritis; Transplantation, Homologous; Uveal Diseases | 1980 |
Necrotic choroidal melanoma with orbital inflammation.
Topics: Anti-Inflammatory Agents; Choroid Neoplasms; Eye Enucleation; Humans; Inflammation; Male; Melanoma; Methylprednisolone; Middle Aged; Necrosis; Orbit; Orbital Diseases; Tomography, X-Ray Computed; Ultrasonography | 1995 |
Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids.
Topics: Animals; Cell Line; Drug Interactions; Glucocorticoids; Hematoporphyrin Photoradiation; Hydrocortisone; Lung Neoplasms; Melanoma; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitivity Disorders; Time Factors | 1985 |